Abbott Laboratories' shares rose due to strong growth in medical devices and diagnostics, driven by innovations like the FreeStyle Libre system, supporting its diversified healthcare portfolio and global expansion.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.